Middle East respiratory syndrome: SARS redux?

Glenn W Wortmann

doi:10.3949/ccjm.82a.15097

Middle East respiratory syndrome: SARS redux?

Cleve Clin J Med. 2015 Sep;82(9):584-8. doi: 10.3949/ccjm.82a.15097.

Author

Glenn W Wortmann^{1

2

3}

Affiliations

¹ Section Chief, Infectious Diseases, Program Director, Infectious Diseases Fellowship, MedStar Washington Hospital Center, Washington, DC, USA. E-mail: Glenn.W.Wortmann@medstar.net.
² Professor of Clinical Medicine (Infectious Disease), Georgetown University, Washington, DC, USA.
³ Professor of Medicine, Adjunct Assistant Professor of Emerging Infectious Diseases, Uniformed Services University of the Health Sciences, Edward Hebert School of Medicine, Bethesda, MD, USA.

PMID: 26366955
DOI: 10.3949/ccjm.82a.15097

Abstract

Middle East respiratory syndrome (MERS) is caused by the Middle East respiratory syndrome coronavirus (MERS-CoV). Although predominantly affecting countries across the Arabian Peninsula, the infection has been exported by travelers to countries around the world, including the United States. The virus has caused several healthcare-related outbreaks, so prompt recognition and patient isolation are critical to containing the spread of infection. Healthcare providers are urged to stay current on the evolving outbreak, and to screen at-risk travelers for possible MERS.

Publication types

Review

MeSH terms

Communicable Disease Control / organization & administration
Coronavirus Infections* / diagnosis
Coronavirus Infections* / epidemiology
Coronavirus Infections* / physiopathology
Coronavirus Infections* / therapy
Coronavirus Infections* / virology
Disease Outbreaks / prevention & control*
Disease Progression
Humans
Middle East Respiratory Syndrome Coronavirus / physiology*
Prognosis
Risk Factors
Travel*